Skip to content

Care Transitions in Renal Disease Patients

Care Transitions in Renal Disease Patients

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01842776
Acronym
CT
Enrollment
3300
Registered
2013-04-30
Start date
2013-03-31
Completion date
2014-12-31
Last updated
2013-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Renal Disease

Brief summary

The goal of this pilot is to reduce the 30-day hospital readmission rate for dialysis patients. It is a quality improvement project that consistent of 4 tracks. Tracks 1 & 2: Implement use of checklists of activities for staff to complete when patients are admitted to the hospital, and post-hospitalization with emphasis on fluid assessment, nutrition management, patient coaching, and communication between institutions. Track 3: Work with physicians to develop process to individualize post-hospitalization dialysis orders and improve medication reconciliation. Track 4: Use a renal Care Transitions Case Manager to follow patients in the hospital and 30 days post-hospitalization to facilitate care and patient coaching.

Interventions

None listed

Sponsors

Amgen
CollaboratorINDUSTRY
Fresenius Medical Care North America
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Chronic hemodialysis patients * All patients admitted to the hospital during the study period

Exclusion criteria

* Patients \<18 years old

Design outcomes

Primary

MeasureTime frameDescription
30-day readmission rateParticipants will be followed for the duration of each hospital stay and 30 days post-hospitalization, for an expected average of 37 days.Number of hospitalizations that occur within 30 days after discharge from an initial index hospitalization (convert to percentage of 30-day readmissions).

Countries

United States

Contacts

Primary ContactRebecca L Wingard, RN, MSN
rebecca.wingard@fmc-na.com615-567-4846
Backup ContactKathryn McDougall, RN, BSN
kathryn.mcdougall@fmc-na.com615-567-4837

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026